The CTN is led by senior investigators committed to improving the lives of individuals with Lyme and other tick-borne diseases.
The focus is treatment, as this is a major clinical need and a much neglected area. The CTN studies will help to shape medical
practice in the United States and elsewhere, as its study results will be published in prominent peer-reviewed journals.
This research however is not possible without the generous participation of the patient community. We thank all study participants
as they play such a vital role in this major public health endeavor!
Treatment research can be of different types. Some treatments are “open-label” meaning that the treatment is known by participant
and doctor. Some are “double-masked” meaning that neither participant nor doctor knows whether the participant is receiving one
medicine, another medicine, or an inactive drug (‘placebo’). Studies generally vary in duration from 2 -6 months. All studies are
conducted under IRB-approved protocols and all participants are carefully monitored for safety and clinical outcome.
The public can learn more about current Lyme and other Tick-borne disease treatment studies by going to www.clinicaltrials.gov.
Just type in the name of the tick-borne disease and you will find a list of current and completed studies.